Salzberg, M. O., Triozzi, P., Kooshki, M., Alistar, A. T., Bitting, R. L., Fenstermaker, J., … Loibner, H. (2016). Adoptive cellular immunotherapy with APN401, autologous Cbl-b-silenced peripheral blood mononuclear cells, in patients with solid tumors. In Journal of Clinical Oncology (Vol. 34, pp. e14541–e14541). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.e14541

Salzberg, Marc Oliver, Pierre Triozzi, Mitra Kooshki, Angela Tatiana Alistar, Rhonda Lynn Bitting, Joyce Fenstermaker, Guenther Lametschwandtner, and Hans Loibner. “Adoptive cellular immunotherapy with APN401, autologous Cbl-b-silenced peripheral blood mononuclear cells, in patients with solid tumors.” In Journal of Clinical Oncology, 34:e14541–e14541. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.e14541.

Salzberg MO, Triozzi P, Kooshki M, Alistar AT, Bitting RL, Fenstermaker J, et al. Adoptive cellular immunotherapy with APN401, autologous Cbl-b-silenced peripheral blood mononuclear cells, in patients with solid tumors. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e14541–e14541.

Salzberg, Marc Oliver, et al. “Adoptive cellular immunotherapy with APN401, autologous Cbl-b-silenced peripheral blood mononuclear cells, in patients with solid tumors.” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. e14541–e14541. Crossref, doi:10.1200/jco.2016.34.15_suppl.e14541.

Salzberg MO, Triozzi P, Kooshki M, Alistar AT, Bitting RL, Fenstermaker J, Lametschwandtner G, Loibner H. Adoptive cellular immunotherapy with APN401, autologous Cbl-b-silenced peripheral blood mononuclear cells, in patients with solid tumors. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. e14541–e14541.